MedTrace Logo

Mirena in Idiopathic Menorrhagia

NCT00868153 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1125

Last updated 2015-02-18

No results posted yet for this study

Summary

This is an open-label, uncontrolled, multi-centre observational study that analyses a follow-up of 1600 women with dysfunctional uterine bleeding (idiopathic menorrhagia) over a period of one year.The patients evaluated at four visits, beginning with the insertion visit and 3, 6 and 12 months after insertion.

Conditions

  • Idiopathic Menorrhagia

Interventions

DRUG

Levonorgestrel IUS (Mirena , BAY86-5028)

One group

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Eligibility

Min Age
30 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-08-31
Primary Completion
2008-11-30
Completion
2008-11-30

Countries

  • Bulgaria
  • Croatia
  • India
  • Jordan
  • Kuwait
  • Pakistan
  • Romania
  • Russia
  • Saudi Arabia
  • Serbia
  • Sri Lanka
  • Turkey (Türkiye)
  • United Arab Emirates

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00868153 on ClinicalTrials.gov